182 related articles for article (PubMed ID: 19441164)
21. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
[TBL] [Abstract][Full Text] [Related]
22. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
[TBL] [Abstract][Full Text] [Related]
24. RASSF10 promoter hypermethylation is frequent in malignant melanoma of the skin but uncommon in nevus cell nevi.
Helmbold P; Richter AM; Walesch S; Skorokhod A; Marsch WCh; Enk A; Dammann RH
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):687-94. PubMed ID: 22113481
[TBL] [Abstract][Full Text] [Related]
25. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
De Araújo ÉS; Kashiwabara AY; Achatz MI; Moredo LF; De Sá BC; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Melanoma Res; 2015 Apr; 25(2):173-7. PubMed ID: 25647737
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic hierarchy within the MAGEA1 cancer-germline gene: promoter DNA methylation dictates local histone modifications.
Cannuyer J; Loriot A; Parvizi GK; De Smet C
PLoS One; 2013; 8(3):e58743. PubMed ID: 23472218
[TBL] [Abstract][Full Text] [Related]
27. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype.
Oue N; Oshimo Y; Nakayama H; Ito R; Yoshida K; Matsusaki K; Yasui W
Cancer Sci; 2003 Oct; 94(10):901-5. PubMed ID: 14556664
[TBL] [Abstract][Full Text] [Related]
29. CpG island methylation profiling in human salivary gland adenoid cystic carcinoma.
Bell A; Bell D; Weber RS; El-Naggar AK
Cancer; 2011 Jul; 117(13):2898-909. PubMed ID: 21692051
[TBL] [Abstract][Full Text] [Related]
30. DNA Methylation Levels of Melanoma Risk Genes Are Associated with Clinical Characteristics of Melanoma Patients.
de Araújo ÉS; Pramio DT; Kashiwabara AY; Pennacchi PC; Maria-Engler SS; Achatz MI; Campos AH; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Biomed Res Int; 2015; 2015():376423. PubMed ID: 26106605
[TBL] [Abstract][Full Text] [Related]
31. MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma.
Falzone L; Salemi R; Travali S; Scalisi A; McCubrey JA; Candido S; Libra M
Aging (Albany NY); 2016 May; 8(5):933-44. PubMed ID: 27115178
[TBL] [Abstract][Full Text] [Related]
32. High frequency of p16(INK4A) promoter methylation in NRAS-mutated cutaneous melanoma.
Jonsson A; Tuominen R; Grafström E; Hansson J; Egyhazi S
J Invest Dermatol; 2010 Dec; 130(12):2809-17. PubMed ID: 20703244
[TBL] [Abstract][Full Text] [Related]
33. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
34. Methylation of CpG island promoters in uveal melanoma.
Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation profiling of 30 genes in human malignant melanoma.
Furuta J; Umebayashi Y; Miyamoto K; Kikuchi K; Otsuka F; Sugimura T; Ushijima T
Cancer Sci; 2004 Dec; 95(12):962-8. PubMed ID: 15596045
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
37. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
38. Correlation between CpG methylation profiles and hormone receptor status in breast cancers.
Feng W; Shen L; Wen S; Rosen DG; Jelinek J; Hu X; Huan S; Huang M; Liu J; Sahin AA; Hunt KK; Bast RC; Shen Y; Issa JP; Yu Y
Breast Cancer Res; 2007; 9(4):R57. PubMed ID: 17764565
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.
Cohen Y; Merhavi-Shoham E; Avraham RB; Frenkel S; Pe'er J; Goldenberg-Cohen N
Exp Eye Res; 2008 Feb; 86(2):201-6. PubMed ID: 18068703
[TBL] [Abstract][Full Text] [Related]
40. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
